Correlation between Galectin-3 and Adverse Outcomes in Myocardial Infarction Patients: A Meta-Analysis

Table 1

Summary details of included studies.

Study	Publication year	Mean follow-up	Number of participants	Type of participants	Observational results
Asleh	2019	5.4 years	1342	Myocardial infarction	Mortality
Di Tano	2017	18 months	103	Myocardial infarction	Mortality
Gagno	2019	12 months	469	Myocardial infarction	Mortality
George	2015	6 months	102	Chronic stable angina, microvascular angina, and myocardial infarction	LVEF
Lisowska	2016	2.8 years	233	Myocardial infarction	Mortality
Mayr	2012	4 months	29	Myocardial infarction	LVEF and infarct size
Singsaas1	2016	4.4 years	52	Myocardial infarction	LVEF and infarct size
Singsaas2	2016	1 year	38	Myocardial infarction	LVEF and infarct size
Szadkowska	2013	3–5 days	145	Myocardial infarction	LVEF
Tsai	2012	30 days	196	Myocardial infarction	LVEF and mortality
Weir	2013	24 weeks	100	Myocardial infarction	LVEF